経口固形製剤CDMOの市場規模、シェア、動向分析レポート：製品別、メカニズム別、薬効別、最終用途別、地域別、セグメント予測、2025年～2030年

経口固形製剤CDMO市場の成長と動向：

経口固形製剤CDMOの世界市場規模は2030年までに635億米ドルに達し、2025年から2030年までのCAGRは6.49%で成長すると予測されます。

製薬企業やバイオ医薬品企業の間で経口固形製剤製造のアウトソーシング需要が増加していることから、開発・製造受託機関（CDMO）は製薬企業の需要をサポートするために製造施設の拡張を余儀なくされています。このような拡張は、経口固形製剤業界への浸透を高めるために世界中で行われています。さらに、OSD製品としてジェネリック医薬品の数が増加しているため、ジェネリック医薬品に対する需要の高まりが市場成長の主な要因となっています。

慢性疾患や感染症に罹患する患者数の増加は、新規治療薬への需要を促進する主な要因であり、それによって業界全体の進展にプラスの影響を与えています。加えて、慢性疾患に罹患しやすい老年人口が急増し、こうした人々の間でOSDの採用率が高いことも、OSDの需要をさらに後押ししています。さらに、既存薬に対する副作用が新たな治療オプションへの需要を高めていることも、市場成長に寄与しています。

経口固形製剤CDMO市場では、製造効率、製品品質、法規制遵守を強化するための技術進歩が続いており、市場全体の成長可能性にプラスの影響を与えています。連続的な製造は、製造ワークフローを合理化し、経口固形製剤の製造における柔軟性を高めることにつながる、多数の単位操作のシームレスな統合を支援します。さらに、クロマトグラフィー、分光法、質量分析、溶出試験などの技術革新により、CDMOは医薬品分析の精度、感度、信頼性を高めることができるようになりました。さらに、自動化、ロボット化、データ分析の統合により、分析ワークフローが合理化され、ターンアラウンドタイムが短縮され、データの整合性が強化され、適正製造基準（GMP）や国際整合化会議（ICH）ガイドラインなどの規制基準に準拠するようになりました。

経口固形製剤CDMO市場レポートハイライト

• 製品別では、錠剤セグメントが2024年の市場を独占。同分野の高い成長は、研究開発活動への投資の増加、製造プロセスの技術的進歩、革新的なドラッグデリバリーオプション、高い市場需要に対応するための高度なソリューションへのニーズの高まりによる。
• メカニズム別では、患者のコンプライアンス向上、有効性と安全性の強化、投与回数の減少などを理由に、放出制御型が2024年に最大の市場シェアを占めました。
• 薬剤の効能別では、低効能薬が2024年に最大の市場シェアを占めました。これは、開発と製造プロセスが容易であること、ジェネリック医薬品の需要が高く、費用対効果の高いソリューションが求められていること、患者人口が多いこと、患者の効果的な転帰を実現するために複数の治療領域に浸透していることなどによる。
• 最終用途別では、中堅・中小企業セグメントが2024年に72.34%以上を占め、収益の大半を占めました。このセグメントの成長は、CDMOやCMOに生産業務をアウトソーシングする中堅・中小企業の増加に起因しています。中堅・中小規模の製薬会社では、製剤開発、プロセスの最適化、経口固形製剤の製造におけるリソースや能力が限られています。そのため、経口固形製剤の開発・製造においてCDMOに対する顧客の嗜好が高まっています。
• 2024年の経口固形製剤CDMO市場は、アジア太平洋地域が36.76%のシェアを占めています。インドや中国を含むアジア諸国への医薬品製造のアウトソーシングが増加しています。このため、同地域で製薬企業が実施する臨床研究が増加しています。さらに、原材料の高い入手可能性と高度な製造インフラが、同地域の市場成長を促進すると思われます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経口固形製剤CDMO市場の変数、動向、および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 補助市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• テクノロジー情勢
  • 製造技術
  • カプセル化技術
  • コーティング技術
  • 包装技術
  • 分析技術
• 価格モデル分析
• 経口固形剤受託製造市場分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 経口固形製剤CDMO市場：製品別推定・動向分析

• セグメントダッシュボード
• 経口固形製剤CDMO市場：製品変動分析
• 世界の経口固形製剤CDMO市場規模と動向分析（製品別、2018～2030年）
• タブレット
  • 圧縮錠
  • 口腔内崩壊錠（ODT）
  • チュアブル錠
  • 二層錠または三層錠
  • 舌下錠またはバッカル錠
  • その他
• カプセル
  • ハードゼラチンカプセル
  • ソフトゼラチンカプセル
• 粉
• 顆粒
• その他

第5章 経口固形製剤CDMO市場：メカニズム別推定・動向分析

• セグメントダッシュボード
• 経口固形製剤CDMO市場：メカニズム変動分析
• 世界の経口固形製剤CDMO市場規模と動向分析（メカニズム別、2018～2030年）
• 即時放出
• 遅延放出
• 制御放出

第6章 経口固形製剤CDMO市場：薬効別推定・動向分析

• セグメントダッシュボード
• 経口固形製剤CDMO市場：薬物の効力変動分析
• 世界の経口固形製剤CDMO市場規模と動向分析（薬効別、2018～2030年）
• 高効力薬物
• 中効力薬物
• 低効力薬物

第7章 経口固形製剤CDMO市場：最終用途別推定・動向分析

• セグメントダッシュボード
• 経口固形製剤CDMO市場：最終用途変動分析
• 世界の経口固形製剤CDMO市場規模と動向分析（最終用途別、2018～2030年）
• 大企業
• 中規模および小規模企業
• その他

第8章 経口固形製剤CDMO市場：地域推定・動向分析、製品別、メカニズム別、薬効別、最終用途別

• 地域ダッシュボード
• 経口固形製剤CDMO市場：地域変動分析
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
  • マーケットリーダー
  • 新興企業
• 企業市場シェア/評価分析、2024年
• 企業プロファイル
  • Lonza
  • Thermo Fisher Scientific Inc.
  • Cambrex Corporation
  • Catalent Inc.
  • Siegrfried Holding AG
  • Recipharm AB
  • CordenPharma International
  • Boehringer Ingelheim
  • Piramal Pharma Solutions
  • Aenova Group
  • Almac Group
  • Jubilant Pharmova Limited
  • Delpharm
  • AbbVie Contract Manufacturing
  • Next Pharma AB
  • Rubicon Research Pvt. Ltd.
  • Quotient Sciences
  • Almac Group
  • SPI Pharma
  • DPT Laboratories Ltd.
  • Alcami Corporation

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 5 Global Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 6 Global Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 7 Global Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 8 Global Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 9 Global Oral Solid Dosage CDMO Market, by Region, 2018 - 2030 (USD Million)
• Table 10 North America Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
• Table 11 North America Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 12 North America Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 13 North America Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 14 North America Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 15 North America Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 16 North America Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 17 U.S Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 18 U.S Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 19 U.S Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 20 U.S Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 21 U.S Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 22 U.S Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 23 Canada Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 24 Canada Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 25 Canada Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 26 Canada Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 27 Canada Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 28 Canada Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 29 Mexico Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 30 Mexico Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 31 Mexico Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 32 Mexico Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 33 Mexico Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 34 Mexico Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 35 Europe Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
• Table 36 Europe Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 37 Europe Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 38 Europe Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 39 Europe Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 40 Europe Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 41 Europe Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 42 Germany Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 43 Germany Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 44 Germany Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 45 Germany Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 46 Germany Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 47 Germany Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 48 UK Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 49 UK Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 50 UK Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 51 UK Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 52 UK Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 53 UK Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 54 France Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 55 France Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 56 France Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 57 France Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 58 France Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 59 France Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 60 Italy Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 61 Italy Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 62 Italy Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 63 Italy Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 64 Italy Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 65 Italy Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 66 Spain Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 67 Spain Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 68 Spain Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 69 Spain Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 70 Spain Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 71 Spain Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 72 Denmark Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 73 Denmark Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 74 Denmark Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 75 Denmark Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 76 Denmark Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 77 Denmark Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 78 Sweden Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 79 Sweden Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 80 Sweden Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 81 Sweden Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 82 Sweden Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 83 Sweden Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 84 Norway Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 85 Norway Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 86 Norway Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 87 Norway Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 88 Norway Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 89 Norway Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 90 Asia Pacific Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
• Table 91 Asia Pacific Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 92 Asia Pacific Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 93 Asia Pacific Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 94 Asia Pacific Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 95 Asia Pacific Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 96 Asia Pacific Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 97 China Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 98 China Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 99 China Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 100 China Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 101 China Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 102 China Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 103 Japan Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 104 Japan Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 105 Japan Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 106 Japan Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 107 Japan Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 108 Japan Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 109 India Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 110 India Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 111 India Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 112 India Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 113 India Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 114 India Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 115 South Korea Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 116 South Korea Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 117 South Korea Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 118 South Korea Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 119 South Korea Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 120 South Korea Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 121 Australia Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 122 Australia Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 123 Australia Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 124 Australia Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 125 Australia Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 126 Australia Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 127 Thailand Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 128 Thailand Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 129 Thailand Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 130 Thailand Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 131 Thailand Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 132 Thailand Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 133 Latin America Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
• Table 134 Latin America Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 135 Latin America Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 136 Latin America Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 137 Latin America Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 138 Latin America Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 139 Latin America Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 140 Brazil Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 141 Brazil Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 142 Brazil Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 143 Brazil Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 144 Brazil Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 145 Brazil Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 146 Argentina Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 147 Argentina Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 148 Argentina Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 149 Argentina Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 150 Argentina Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 151 Argentina Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 152 Middle East & Africa Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
• Table 153 Middle East & Africa Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 154 Middle East & Africa Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 155 Middle East & Africa Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 156 Middle East & Africa Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 157 Middle East & Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 158 Middle East & Africa Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 159 South Africa Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 160 South Africa Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 161 South Africa Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 162 South Africa Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 163 South Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 164 South Africa Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 165 Saudi Arabia Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 166 Saudi Arabia Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 167 Saudi Arabia Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 168 Saudi Arabia Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 169 Saudi Arabia Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 170 Saudi Arabia Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 171 UAE Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 172 UAE Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 173 UAE Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 174 UAE Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 175 UAE Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 176 UAE Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
• Table 177 Kuwait Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
• Table 178 Kuwait Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
• Table 179 Kuwait Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
• Table 180 Kuwait Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 181 Kuwait Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
• Table 182 Kuwait Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Oral Solid Dosage CDMO, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Regional Marketplace: Key Takeaways
• Fig. 12 Global Oral Solid Dosage CDMO, for Tablets, 2018 - 2030 (USD Million)
• Fig. 13 Global Oral Solid Dosage CDMO, for Compressed Tablets, 2018 - 2030 (USD Million)
• Fig. 14 Global Oral Solid Dosage CDMO, for Orally Disintegrating Tablets (ODT), 2018 - 2030 (USD Million)
• Fig. 15 Global Oral Solid Dosage CDMO, for Chewable Tablets, 2018 - 2030 (USD Million)
• Fig. 16 Global Oral Solid Dosage CDMO, for Bi-layer or Tri-layer Tablets, 2018 - 2030 (USD Million)
• Fig. 17 Global Oral Solid Dosage CDMO, for Sublingual or Buccal Tablets, 2018 - 2030 (USD Million)
• Fig. 18 Global Oral Solid Dosage CDMO, for Others, 2018 - 2030 (USD Million)
• Fig. 19 Global Oral Solid Dosage CDMO, for Hard Gelatin Capsules, 2018 - 2030 (USD Million)
• Fig. 20 Global Oral Solid Dosage CDMO, for Soft Gelatin Capsules, 2018 - 2030 (USD Million)
• Fig. 21 Global Oral Solid Dosage CDMO, for Immediate Release, 2018 - 2030 (USD Million)
• Fig. 22 Global Oral Solid Dosage CDMO, for Delayed Release, 2018 - 2030 (USD Million)
• Fig. 23 Global Oral Solid Dosage CDMO, for Controlled Release, 2018 - 2030 (USD Million)
• Fig. 24 Global Oral Solid Dosage CDMO, for High Potent Drugs, 2018 - 2030 (USD Million)
• Fig. 25 Global Oral Solid Dosage CDMO, for Moderate Potent Drugs, 2018 - 2030 (USD Million)
• Fig. 26 Global Oral Solid Dosage CDMO, for Low Potent Drugs, 2018 - 2030 (USD Million)
• Fig. 27 Global Oral Solid Dosage CDMO, for Large Size Companies, 2018 - 2030 (USD Million)
• Fig. 28 Global Oral Solid Dosage CDMO, for Medium & Small Size Companies, 2018 - 2030 (USD Million)
• Fig. 29 Global Oral Solid Dosage CDMO, for Others, 2018 - 2030 (USD Million)
• Fig. 30 Regional Outlook, 2023 & 2030
• Fig. 31 North America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 U.S. Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Canada Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Mexico Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Europe Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Germany Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 UK Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 France Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Italy Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Spain Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Denmark Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Sweden Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Norway Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Asia Pacific Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Japan Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 China Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 India Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Australia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 South Korea Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Thailand Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Latin America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Brazil Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Argentina Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Middle East and Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 South Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 UAE Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Oral Solid Dosage CDMO Market Growth & Trends:

The global oral solid dosage CDMO market size is expected to reach USD 63.50 billion by 2030, and grow at a CAGR of 6.49% from 2025 to 2030. The increasing demand for outsourcing oral solid dosage manufacturing among pharmaceutical and biopharmaceutical companies has compelled contract development and manufacturing organizations (CDMO) to expand their manufacturing facilities to support the demand of pharmaceutical companies. These expansions are made across the globe to enhance their oral solid dosage industry penetration. Furthermore, the rising demand for generic drugs is a key factor for the market growth as there are increasing numbers of generics as OSD products.

The growing number of patients suffering from chronic and infectious diseases is key factor driving demand for novel therapeutics, thereby positively influencing overall industry progression. In addition, Booming geriatric population that are highly prone to chronic diseases and high adoption rate of OSD among this population further supporting the demand for OSD. Furthermore, another factor contributing to the market growth is adverse drug reactions to existing drugs, which have increased the demand for novel treatment options.

Ongoing technological advancements in the oral solid dosage CDMO market to enhance manufacturing efficiency, product quality, and regulatory compliance are positively influencing overall market growth potential. Continuous manufacturing assists seamless integration of numerous unit operations leading to streamlined production workflows and increased flexibility in manufacturing oral solid dosage forms. Moreover, innovations in techniques such as chromatography, spectroscopy, mass spectrometry, and dissolution testing enabled CDMOs to meet enhanced precision, sensitivity, & reliability in pharmaceutical analysis. Furthermore, the integration of automation, robotics, & data analytics streamlined analytical workflows, reduced turnaround times, and enhanced data integrity & compliance with regulatory standards such as Good Manufacturing Practices (GMP) & International Council for Harmonization (ICH) guidelines.

Oral Solid Dosage CDMO Market Report Highlights:

• Basd on product, the tablets segment dominated the market in 2024. The high segment growth is driven by increasing investment in research and development activities, technological advancements in manufacturing processes, innovative drug delivery options and the growing need for advanced solutions to cater to high market demand.
• Based on the mechanism, controlled release segment held the largest market share in 2024 attributing to an improved patient compliance, enhanced efficacy & safety, and reduced frequency of administration.
• Based on the drug potency, low potent drugs segment held the largest market share in 2024 owing to ease of development and manufacturing processes, high demand for generic drugs coupled with need for cost effective solutions, high patient population and high penetration among multiple therapeutic areas to cater effective patient outcome.
• Based on end use, medium & small-size companies segment held the majority revenue share, accounting for over 72.34% in 2024. Growth in the segment can be attributed to the increasing number of small- & medium-sized companies outsourcing their production work to CDMOs and CMOs. Medium and small-sized pharmaceutical companies have limited resources and capabilities in formulation development, process optimization, and manufacturing of oral solid dosage forms. Thus, growing customer preference towards CDMOs for the development and manufacturing of oral solid dosage.
• Asia Pacific dominated the oral solid dosage CDMO market with a share of 36.76% in 2024. The outsourcing of pharmaceutical manufacturing to Asian countries, including India and China, has increased due to their lower costs and availability of potential study subjects. This has led to an increase in clinical studies conducted by pharmaceutical companies in the region. Moreover, high availability of raw materials and advanced manufacturing infrastructure will propel regional market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Details of primary research
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Value Chain-Based Sizing & Forecasting (Model 2)
  • 1.7.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.7.4. Bottom-up Approach (Model 4)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. List of Abbreviations
• 1.11. Objectives
  • 1.11.1. Objective 1
  • 1.11.2. Objective 2
  • 1.11.3. Objective 3
  • 1.11.4. Objective 4

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Oral Solid Dosage CDMO Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
    • 3.2.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
    • 3.2.1.3. Increasing Demand for Novel Therapies
    • 3.2.1.4. Increasing Demand for One-Stop-Shop CMOs
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Strict Approval Criteria by Regulatory Authorities
    • 3.2.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
    • 3.2.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
• 3.3. Technology Landscape
  • 3.3.1. Manufacturing Technology
  • 3.3.2. Encapsulation Technology
  • 3.3.3. Coating Technology
  • 3.3.4. Packaging Technology
  • 3.3.5. Analytical Technology
• 3.4. Pricing Model Analysis
• 3.5. Oral Solid Dosage Contract Manufacturing Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Oral Solid Dosage CDMO Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Oral Solid Dosage CDMO Market: Product Movement Analysis
• 4.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Tablets
  • 4.4.1. Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Compressed Tablets
    • 4.4.2.1. Compressed Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Orally Disintegrating Tablets (ODT)
    • 4.4.3.1. Orally Disintegrating Tablets (ODT) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Chewable Tablets
    • 4.4.4.1. Chewable Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Bi-layer or Tri-layer Tablets
    • 4.4.5.1. Bi-layer or Tri-layer Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.6. Sublingual or Buccal Tablets
    • 4.4.6.1. Sublingual or Buccal Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Capsules
  • 4.5.1. Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Hard Gelatin Capsules
    • 4.5.2.1. Hard Gelatin Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Soft Gelatin Capsules
    • 4.5.3.1. Soft Gelatin Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Powder
  • 4.6.1. Powder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Granules
  • 4.7.1. Granules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Oral Solid Dosage CDMO Market: Mechanism Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Oral Solid Dosage CDMO Market: Mechanism Movement Analysis
• 5.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
• 5.4. Immediate Release
  • 5.4.1. Immediate Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Delayed Release
  • 5.5.1. Delayed Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Controlled Release
  • 5.6.1. Controlled Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Oral Solid Dosage CDMO Market: Drug Potency Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Oral Solid Dosage CDMO Market: Drug Potency Movement Analysis
• 6.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Drug Potency, 2018 to 2030 (USD Million)
• 6.4. High Potent Drugs
  • 6.4.1. High Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Moderate Potent Drugs
  • 6.5.1. Moderate Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Low Potent Drugs
  • 6.6.1. Low Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Oral Solid Dosage CDMO Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Oral Solid Dosage CDMO Market: End Use Movement Analysis
• 7.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Large Size Companies
  • 7.4.1. Large Size Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Medium & Small Size Companies
  • 7.5.1. Medium & Small Size Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Oral Solid Dosage CDMO Market: Regional Estimates & Trend Analysis, by Product, by Mechanism, by Drug Potency, by End Use

• 8.1. Regional Dashboard
• 8.2. Oral Solid Dosage CDMO Market: Regional Movement Analysis
• 8.3. North America
  • 8.3.1. North America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Market Share/Assessment Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. Lonza
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product/Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Thermo Fisher Scientific Inc.
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product/Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Cambrex Corporation
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product/Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Catalent Inc.
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product/Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Siegrfried Holding AG
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product/Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Recipharm AB
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product/Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. CordenPharma International
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product/Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Boehringer Ingelheim
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product/Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Piramal Pharma Solutions
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product/Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Aenova Group
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product/Service Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. Almac Group
    • 9.3.11.1. Company Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Product/Service Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. Jubilant Pharmova Limited
    • 9.3.12.1. Company Overview
    • 9.3.12.2. Financial Performance
    • 9.3.12.3. Product/Service Benchmarking
    • 9.3.12.4. Strategic Initiatives
  • 9.3.13. Delpharm
    • 9.3.13.1. Company Overview
    • 9.3.13.2. Financial Performance
    • 9.3.13.3. Product/Service Benchmarking
    • 9.3.13.4. Strategic Initiatives
  • 9.3.14. AbbVie Contract Manufacturing
    • 9.3.14.1. Company Overview
    • 9.3.14.2. Financial Performance
    • 9.3.14.3. Product/Service Benchmarking
    • 9.3.14.4. Strategic Initiatives
  • 9.3.15. Next Pharma AB
    • 9.3.15.1. Company Overview
    • 9.3.15.2. Financial Performance
    • 9.3.15.3. Product/Service Benchmarking
    • 9.3.15.4. Strategic Initiatives
  • 9.3.16. Rubicon Research Pvt. Ltd.
    • 9.3.16.1. Company Overview
    • 9.3.16.2. Financial Performance
    • 9.3.16.3. Product/Service Benchmarking
    • 9.3.16.4. Strategic Initiatives
  • 9.3.17. Quotient Sciences
    • 9.3.17.1. Company Overview
    • 9.3.17.2. Financial Performance
    • 9.3.17.3. Product/Service Benchmarking
    • 9.3.17.4. Strategic Initiatives
  • 9.3.18. Almac Group
    • 9.3.18.1. Company Overview
    • 9.3.18.2. Financial Performance
    • 9.3.18.3. Product/Service Benchmarking
    • 9.3.18.4. Strategic Initiatives
  • 9.3.19. SPI Pharma
    • 9.3.19.1. Company Overview
    • 9.3.19.2. Financial Performance
    • 9.3.19.3. Product/Service Benchmarking
    • 9.3.19.4. Strategic Initiatives
  • 9.3.20. DPT Laboratories Ltd.
    • 9.3.20.1. Company Overview
    • 9.3.20.2. Financial Performance
    • 9.3.20.3. Product/Service Benchmarking
    • 9.3.20.4. Strategic Initiatives
  • 9.3.21. Alcami Corporation
    • 9.3.21.1. Company Overview
    • 9.3.21.2. Financial Performance
    • 9.3.21.3. Product/Service Benchmarking
    • 9.3.21.4. Strategic Initiatives